Lumia, a company developing a continuous blood flow tracking wearable, has announced it has successfully raised $7,000,000 in its latest funding round. The investment capital will support the company's mission to address the needs of over 100 million Americans impacted by chronic neurological and cardiovascular conditions. Lumia is focused on creating the world’s first and only continuous blood flow tracking wearable, initially targeting wellness for individuals experiencing symptoms such as dizziness, brain fog, fatigue, and fainting when standing. These symptoms are commonly associated with conditions like Long COVID, Postural Orthostatic Tachycardia Syndrome (POTS), Orthostatic Hypotension, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), and general orthostatic intolerance.
This substantial infusion of capital marks a significant milestone for Lumia as it progresses towards bringing its innovative technology to market. The funding demonstrates investor confidence in Lumia's approach to health technology, particularly its focus on a previously underserved area of continuous physiological monitoring. The company believes its wearable will offer valuable insights for those managing complex conditions where real-time blood flow data can be crucial for understanding symptom patterns and overall well-being.
Lumia plans to strategically deploy the newly secured funds to accelerate product development, expand its research and development capabilities, and scale its operational infrastructure. A core focus will be on refining the technology to ensure accuracy and user comfort, alongside preparing for broader market introduction. The investment is expected to bolster Lumia’s efforts to establish its continuous blood flow tracking wearable as a vital tool for improving the quality of life for individuals grappling with debilitating chronic conditions. The company looks ahead to a period of significant growth, aiming to solidify its position as a leader in personalized health monitoring for neurological and cardiovascular health.
